Lars Fruergaard Jørgensen might not be a household name, but his company’s drug is. And its success has thrust him — ...

Privately-held Cambridge, USA-based biotech Gensaic announced a potentially lucrative license and discovery collaboration ...

American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...

Lars Fruergaard Jørgensen is a CEO who didn't want to be CEO but under his tenure Novo Nordisk, which makes Ozempic, has ...

A new survey has shown which companies in Denmark are trusted the most and least. Novo Nordisk is at the top, followed by ...

Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...

Accordingly, shareholders can choose between participating in person at Bella Center, Center Boulevard 5, DK-2300 Copenhagen ...

Novo Nordisk thrives despite competition and explore its breakthrough amycretin study. Read here to know why we rate NVO ...

Denmark will increase its military budget by a combined 50 billion crowns ($6.99 billion) this year and next to address acute ...

Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift ...

Total deal value of up to $354 million in upfront, development, and commercial milestone payments per target plus tiered ...

Accordingly, shareholders can choose between participating in person at Bella Center, Center Boulevard 5, DK-2300 Copenhagen S, Denmark or ... Also, Novo Nordisk offers the possibility of viewing ...